drugset / Trial / NCT02688270

Efficacy and Safety of Vascana® in Subjects With Secondary Raynaud's Phenomenon

NCT02688270

Phase 2 Completed 65 enrolled Covis Pharma S.à.r.l.
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine the ability of Vascana (0.9% nitroglycerin topical cream) to treat and prevent the symptoms experienced by subject's with Raynaud's Phenomenon. The symptoms of this disease include pain, tingling, and numbness in the fingers of the affected hand or hands.

Timeline

Start
2016-06
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitroglycerin Unknown 0.9 % Topical

Indications